Human Genome Epidemiology Literature Finder
|
Records 1 - 26 (of 26 Records) |
| Query Trace: Colorectal Neoplasms and ERCC2[original query] |
|---|
| Genotype phenotype correlations in Israeli colorectal cancer patients. International journal of cancer. Journal international du cancer 2005 Mar 114 (1): 58-73. Starinsky Sigal, Figer Arie, Ben-Asher Edna, Geva Ravit, Flex Dov, Fidder Herma H, Zidan Jamal, Lancet Doron, Friedman Eit |
| Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Apr 12 (7 Pt 1): 2101-8. Moreno Victor, Gemignani Federica, Landi Stefano, Gioia-Patricola Lydie, Chabrier Amélie, Blanco Ignacio, González Sara, Guino Elisabet, Capellà Gabriel, Canzian Federi |
| Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome. Pharmacogenomics 2007 Dec 8 (12): 1693-703. Le Morvan Valérie, Smith Denis, Laurand Armelle, Brouste Véronique, Bellott Ricardo, Soubeyran Isabelle, Mathoulin-Pelissier Simone, Robert Jacqu |
| Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jun 26 (16): 2690-8. Braun Michael S, Richman Susan D, Quirke Philip, Daly Catherine, Adlard Julian W, Elliott Faye, Barrett Jennifer H, Selby Peter, Meade Angela M, Stephens Richard J, Parmar Mahesh K B, Seymour Matthew |
| ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC cancer 2008 8 (1): 50. Huang Ming-Yii, Fang Wei-Yu, Lee Su-Chen, Cheng Tian-Lu, Wang Jaw-Yuan, Lin Shiu- |
| Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Nov 27 (33): 5519-28. Braun Michael S, Richman Susan D, Thompson Lindsay, Daly Catherine L, Meade Angela M, Adlard Julian W, Allan James M, Parmar Mahesh K B, Quirke Philip, Seymour Matthew |
| Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 May 28 (15): 2556-64. Boige Valérie, Mendiboure Jean, Pignon Jean-Pierre, Loriot Marie-Anne, Castaing Marine, Barrois Michel, Malka David, Trégouët David-Alexandre, Bouché Olivier, Le Corre Delphine, Miran Isabelle, Mulot Claire, Ducreux Michel, Beaune Philippe, Laurent-Puig Pier |
| Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients. British journal of clinical pharmacology 2010 Jan 69 (1): 58-66. Etienne-Grimaldi Marie-Christine, Milano Gérard, Maindrault-Goebel Frédérique, Chibaudel Benoist, Formento Jean-Louis, Francoual Mireille, Lledo Gérard, André Thierry, Mabro May, Mineur Laurent, Flesch Michel, Carola Elisabeth, de Gramont Aime |
| ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Mar 17 (6): 1632-40. Yin Ming, Yan Jingrong, Martinez-Balibrea Eva, Graziano Francesco, Lenz Heinz-Josef, Kim Hyo-Jin, Robert Jacques, Im Seock-Ah, Wang Wei-Shu, Etienne-Grimaldi Marie-Christine, Wei Qing |
| Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers? Molecular diagnosis & therapy 2011 Oct 15 (5): 277-83. Fariña Sarasqueta Arantza, van Lijnschoten Gesina, Lemmens Valery E P P, Rutten Harm J T, van den Brule Adriaan J |
| GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. Asian Pacific journal of cancer prevention : APJCP 2012 13 (7): 3465-9. Li Hui-Yan, Ge Xin, Huang Guang-Ming, Li Kai-Yu, Zhao Jing-Quan, Yu Xi-Miao, Bi Wen-Si, Wang Yu-L |
| Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. Cancer chemotherapy and pharmacology 2013 Jun 71 (6): 1463-72. Cortejoso Lucía, García María I, García-Alfonso Pilar, González-Haba Eva, Escolar Fernando, Sanjurjo María, López-Fernández Luis |
| Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients. Oncology letters 2013 Sep 6 (3): 648-654. Kumamoto Kensuke, Ishibashi Keiichiro, Okada Norimichi, Tajima Yusuke, Kuwabara Kouki, Kumagai Yoichi, Baba Hiroyuki, Haga Norihiro, Ishida Hideyu |
| Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Scientific reports 2014 4 4112. Ni Min, Zhang Wei-zhong, Qiu Jin-rong, Liu Fei, Li Min, Zhang Ya-jie, Liu Qing, Bai J |
| AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The pharmacogenomics journal 2015 Aug . Kjersem J B, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit K M, Wettergren Y, Kure E |
| An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population. Cancer biomarkers : section A of Disease markers 2015 Jun 15 (4): 413-23. Kabzinski Jacek, Przybylowska Karolina, Dziki Lukasz, Dziki Adam, Majsterek Ireneu |
| Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis. Pharmacogenomics 2016 Sep . Shahnam Adel, Ridha Zainab, Wiese Michael D, Kichenadasse Ganessan, Sorich Michael |
| Polymorphisms of DNA repair genes are associated with colorectal cancer in patients with Lynch syndrome. Molecular genetics & genomic medicine 2018 Apr . Kamiza Abram B, Hsieh Ling-Ling, Tang Reiping, Chien Huei-Tzu, Lai Chih-Hsiung, Chiu Li-Ling, Lo Tsai-Ping, Hung Kuan-Yi, You Jeng-Fu, Wang Wen-Chang, Hsiung Chao A, Yeh Chih-Chi |
| Integrated Analysis of Germline and Tumor DNA Identifies New Candidate Genes Involved in Familial Colorectal Cancer. Cancers 2019 Mar 11 (3): . Díaz-Gay Marcos, Franch-Expósito Sebastià, Arnau-Collell Coral, Park Solip, Supek Fran, Muñoz Jenifer, Bonjoch Laia, Gratacós-Mulleras Anna, Sánchez-Rojas Paula A, Esteban-Jurado Clara, Ocaña Teresa, Cuatrecasas Miriam, Vila-Casadesús Maria, Lozano Juan José, Parra Genis, Laurie Steve, Beltran Sergi, , Castells Antoni, Bujanda Luis, Cubiella Joaquín, Balaguer Francesc, Castellví-Bel Ser |
| Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India. Journal of clinical pharmacy and therapeutics 2020 May . Varma Ashok, Mathaiyan Jayanthi, Shewade Deepak, Dubashi Biswajit, Sunitha Kodide |
| Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. BMC cancer 2020 May 20 (1): 409. Salimzadeh Hamideh, Lindskog Elinor Bexe, Gustavsson Bengt, Wettergren Yvonne, Ljungman Dav |
| Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer. World journal of gastroenterology 2020 Jan 26 (3): 307-323. Li Yan-Ke, Xu Qian, Sun Li-Ping, Gong Yue-Hua, Jing Jing-Jing, Xing Cheng-Zhong, Yuan Yu |
| Longitudinal change of genetic variations in cetuximab-treated metastatic colorectal cancer. Cancer genetics 2021 7 258-259 27-36. Kim Sun Young, Kim Kwoneel, Cho Su Han, Chun Sung-Min, Tak Eunyoung, Hong Yong Sang, Kim Jeong Eun, Kim Tae W |
| Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 Dec . Park Hanla A, Seibold Petra, Edelmann Dominic, Benner Axel, Canzian Federico, Alwers Elizabeth, Jansen Lina, Schneider Martin, Hoffmeister Michael, Brenner Hermann, Chang-Claude Jen |
| Survey of Germline Variants in Cancer-Associated Genes in Young Adults with Colorectal Cancer. Genes, chromosomes & cancer 2021 Nov . Mikaeel Reger R, Young Joanne P, Li Yun, Smith Eric, Horsnell Mehgan, Uylaki Wendy, Tapia Rico Gonzalo, Poplawski Nicola K, Hardingham Jennifer E, Tomita Yoko, Townsend Amanda R, Feng Jinghua, Zibat Arne, Kaulfuß Silke, Müller Christian, Yigit Gökhan, Wollnik Bernd, Price Timothy |
| Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis. Frontiers in genetics 2022 11 13 1009938. Yi Chuncheng, Li Tiandong, Shen Yajing, Wang Peng, Dai Liping, Shi Jianxiang, Wang Keyan, Sun Changqing, Ye H |
- Page last reviewed:Feb 1, 2024
- Content source: